Martin Haluzik served on advisory panel for Eli Lilly, Novo Nordisk, Sanofi, AstraZeneca, Mundipharma
The associated nausea and vomiting can be severe enough to incapacitate the individual who may be unable to walk or talk and/or be bedridden
Fatigue, dizziness, and confusion might be dismissed as normal side effects of the medication or attributed to the caloric restriction that often accompanies GLP-1 therapy
Discontinuation should be planned with a healthcare professional to ensure appropriate diabetes management strategies are in place and to monitor for complications
A long-term study of AAV gene therapy in dogs with hemophilia A identifies clonal expansions of transduced liver cells
30 : 555559 Janiri L, Falcone M, Persico A, Tempesta E